Gastroenteritis refers to the inflammation of the stomach, small intestine, and large intestine. The majority of acute gastrointestinal illnesses (AGIs) are caused by viruses like Norovirus or Rotavirus, as well as bacterial pathogens such as Clostridioides difficile (C. difficile).

The Vivalytic Rota-, Norovirus and C. difficile Panel is capable of detecting these three common gastrointestinal pathogens. With a rapid and accurate time-to-result, this state-of-the-art test enables swift identification of multiple targets,  leading to improved patient outcomes and efficient management of gastrointestinal illnesses.

Noroviruses, often referred to as winter-vomiting disease or stomach flu, are notorious for their rapid spread among human populations, particularly during the winter season. They are highly contagious and account for the majority of gastrointestinal infections. On the other hand, Rotaviruses are responsible for severe diarrheal illness, primarily affecting infants and young children. Transmission of these pathogens commonly occurs within healthcare institutions, including patient-to-patient contact, contaminated hands of healthcare workers, or through environmental contamination.

The Vivalytic Norovirus Panel, specifically engineered to detect the presence of Norovirus (genogroup I/II) in various clinical specimens to facilitate streamlined healthcare practices. By empowering healthcare providers with advanced capabilities, this diagnostic tool enhances their ability to combat Norovirus infections and implement necessary preventive measures in various settings, including hospitals, long-term care facilities, and schools.

Gastroenteritis refers to the inflammation of the stomach, small intestine, and large intestine. The primary cause of acute gastrointestinal illnesses (AGI) is viral infections, particularly Norovirus and Rotavirus, while bacterial pathogens like Clostridioides difficile (C. difficile) can also be responsible. C. difficile is an anaerobic bacterium found widely in soil and the intestinal tracts of animals. The clinical spectrum of C. difficile infection (CDI) varies from mild diarrhoea to severe and life-threatening pseudomembranous colitis. Transmission mainly occurs within healthcare settings such as hospitals, through patient-to-patient contact, contaminated hands of healthcare workers, or environmental contamination.

The Vivalytic C. difficile panel is specifically designed to detect the presence of Clostridioides difficile toxin genes tcdA and tcdB from liquid or soft human stool samples to enhance healthcare practices. With its advanced capabilities, this diagnostic tool empowers healthcare providers in their efforts to combat C. difficile infections, contributing to more effective management of this challenging condition.